10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Genome-scale metabolic rewiring improves titers rates and yields of the non-native product indigoidine at scale

      research-article

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          High titer, rate, yield (TRY), and scalability are challenging metrics to achieve due to trade-offs between carbon use for growth and production. To achieve these metrics, we take the minimal cut set (MCS) approach that predicts metabolic reactions for elimination to couple metabolite production strongly with growth. We compute MCS solution-sets for a non-native product indigoidine, a sustainable pigment, in Pseudomonas putida KT2440, an emerging industrial microbe. From the 63 solution-sets, our omics guided process identifies one experimentally feasible solution requiring 14 simultaneous reaction interventions. We implement a total of 14 genes knockdowns using multiplex-CRISPRi. MCS-based solution shifts production from stationary to exponential phase. We achieve 25.6 g/L, 0.22 g/l/h, and ~50% maximum theoretical yield (0.33 g indigoidine/g glucose). These phenotypes are maintained from batch to fed-batch mode, and across scales (100-ml shake flasks, 250-ml ambr®, and 2-L bioreactors).

          Abstract

          The trade-off between growth and production affects the application of engineered microbes. Here, the authors take the minimal cut set approach to predict metabolic reactions for elimination to couple metabolite production strongly with growth and achieve high production of indigoidine in Pseudomonas putida.

          Related collections

          Most cited references80

          • Record: found
          • Abstract: found
          • Article: not found

          Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system.

          The microbial adaptive immune system CRISPR mediates defense against foreign genetic elements through two classes of RNA-guided nuclease effectors. Class 1 effectors utilize multi-protein complexes, whereas class 2 effectors rely on single-component effector proteins such as the well-characterized Cas9. Here, we report characterization of Cpf1, a putative class 2 CRISPR effector. We demonstrate that Cpf1 mediates robust DNA interference with features distinct from Cas9. Cpf1 is a single RNA-guided endonuclease lacking tracrRNA, and it utilizes a T-rich protospacer-adjacent motif. Moreover, Cpf1 cleaves DNA via a staggered DNA double-stranded break. Out of 16 Cpf1-family proteins, we identified two candidate enzymes from Acidaminococcus and Lachnospiraceae, with efficient genome-editing activity in human cells. Identifying this mechanism of interference broadens our understanding of CRISPR-Cas systems and advances their genome editing applications.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            CRISPR provides acquired resistance against viruses in prokaryotes.

            Clustered regularly interspaced short palindromic repeats (CRISPR) are a distinctive feature of the genomes of most Bacteria and Archaea and are thought to be involved in resistance to bacteriophages. We found that, after viral challenge, bacteria integrated new spacers derived from phage genomic sequences. Removal or addition of particular spacers modified the phage-resistance phenotype of the cell. Thus, CRISPR, together with associated cas genes, provided resistance against phages, and resistance specificity is determined by spacer-phage sequence similarity.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Purification of RNA using TRIzol (TRI reagent).

              TRIzol solubilization and extraction is a relatively recently developed general method for deproteinizing RNA. This method is particularly advantageous in situations where cells or tissues are enriched for endogenous RNases or when separation of cytoplasmic RNA from nuclear RNA is impractical. TRIzol (or TRI Reagent) is a monophasic solution of phenol and guanidinium isothiocyanate that simultaneously solubilizes biological material and denatures protein. After solubilization, the addition of chloroform causes phase separation (much like extraction with phenol:chloroform:isoamyl alcohol), where protein is extracted to the organic phase, DNA resolves at the interface, and RNA remains in the aqueous phase. Therefore, RNA, DNA, and protein can be purified from a single sample (hence, the name TRIzol). TRIzol extraction is also an effective method for isolating small RNAs, such as microRNAs, piwi-associated RNAs, or endogeneous, small interfering RNAs. However, TRIzol is expensive and RNA pellets can be difficult to resuspend. Thus, the use of TRIzol is not recommend when regular phenol extraction is practical.
                Bookmark

                Author and article information

                Contributors
                amukhopadhyay@lbl.gov
                Journal
                Nat Commun
                Nat Commun
                Nature Communications
                Nature Publishing Group UK (London )
                2041-1723
                23 October 2020
                23 October 2020
                2020
                : 11
                : 5385
                Affiliations
                [1 ]GRID grid.184769.5, ISNI 0000 0001 2231 4551, Joint BioEnergy Institute, , Lawrence Berkeley National Laboratory, ; Emeryville, CA 94608 USA
                [2 ]GRID grid.184769.5, ISNI 0000 0001 2231 4551, Biological Systems and Engineering Division, , Lawrence Berkeley National Laboratory, ; Berkeley, CA 94720 USA
                [3 ]GRID grid.184769.5, ISNI 0000 0001 2231 4551, Advanced Biofuel and Bioproduct Process Development Unit, , Lawrence Berkeley National Laboratory, ; Emeryville, CA 94608 USA
                [4 ]GRID grid.184769.5, ISNI 0000 0001 2231 4551, Joint Genome Institute, , Lawrence Berkeley National Laboratory, ; Berkeley, CA 94720 USA
                [5 ]GRID grid.47840.3f, ISNI 0000 0001 2181 7878, QB3 Institute, University of California-Berkeley, ; 5885 Hollis Street, 4th Floor, Emeryville, CA 94608 USA
                [6 ]GRID grid.47840.3f, ISNI 0000 0001 2181 7878, Department of Chemical & Biomolecular Engineering, , University of California, ; Berkeley, CA 94720 USA
                [7 ]GRID grid.47840.3f, ISNI 0000 0001 2181 7878, Department of Bioengineering, , University of California, ; Berkeley, CA 94720 USA
                [8 ]GRID grid.5170.3, ISNI 0000 0001 2181 8870, Novo Nordisk Foundation Center for Biosustainability, , Technical University Denmark, ; 2970 Horsholm, Denmark
                [9 ]Synthetic Biochemistry Center, Institute for Synthetic Biology, Shenzhen Institutes for Advanced Technologies, Shenzhen, China
                [10 ]GRID grid.184769.5, ISNI 0000 0001 2231 4551, Environmental Genomics and Systems Biology Division, , Lawrence Berkeley National Laboratory, ; Berkeley, CA 94720 USA
                Author information
                http://orcid.org/0000-0002-0083-0608
                http://orcid.org/0000-0002-4974-3863
                http://orcid.org/0000-0002-9983-5707
                http://orcid.org/0000-0002-9174-1562
                http://orcid.org/0000-0001-5614-1951
                http://orcid.org/0000-0002-8270-5228
                http://orcid.org/0000-0003-4170-6088
                http://orcid.org/0000-0002-6513-7425
                Article
                19171
                10.1038/s41467-020-19171-4
                7584609
                33097726
                047ee75a-d75b-4307-bb82-0a1722c559cf
                © The Author(s) 2020

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 26 June 2020
                : 30 September 2020
                Funding
                Funded by: FundRef https://doi.org/10.13039/100000015, U.S. Department of Energy (DOE);
                Award ID: DE-AC02-05CH11231
                Award Recipient :
                Categories
                Article
                Custom metadata
                © The Author(s) 2020

                Uncategorized
                metabolic engineering,applied microbiology,synthetic biology
                Uncategorized
                metabolic engineering, applied microbiology, synthetic biology

                Comments

                Comment on this article